Skip to main content
. 2024 Oct 11;6(12):100913. doi: 10.1016/j.xkme.2024.100913

Figure 6.

Figure 6

Risk of bias assessment of observational studies of imipenem-cilastatin. Adapted from the Joanna Briggs Institute Critical Appraisal Checklist.